<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2020-7-1-0-9</article-id><article-id pub-id-type="publisher-id">2328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Medicine (miscellaneous)</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Induced preterm birth: evaluation of oxidative status, matrix metalloproteinases and their tissue inhibitors in amniotic fluid&lt;/strong&gt;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Induced preterm birth: evaluation of oxidative status, matrix metalloproteinases and their tissue inhibitors in amniotic fluid&lt;/strong&gt;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Remneva</surname><given-names>Olga V.</given-names></name><name xml:lang="en"><surname>Remneva</surname><given-names>Olga V.</given-names></name></name-alternatives><email>rolmed@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Korenovsky</surname><given-names>Yuri V.</given-names></name><name xml:lang="en"><surname>Korenovsky</surname><given-names>Yuri V.</given-names></name></name-alternatives><email>timidin@gmail.com</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>M.</surname><given-names>Nellya Михайловна</given-names></name><name xml:lang="en"><surname>M.</surname><given-names>Nellya</given-names></name></name-alternatives><email>nemix@bk.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Kolyado</surname><given-names>Olga V.</given-names></name><name xml:lang="en"><surname>Kolyado</surname><given-names>Olga V.</given-names></name></name-alternatives><email>kolyado.ov@gmail.com</email></contrib></contrib-group><pub-date pub-type="epub"><year>2021</year></pub-date><volume>7</volume><issue>1</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2021/1/document-88-97.pdf" /><abstract xml:lang="ru"><p>Background:&amp;nbsp;Hypoxic brain injury is the most common pathology in newborns. New criteria of viability and progress of perinatal technologies results in high neurological morbidity of surviving very early preterm infants. The aim of the study:&amp;nbsp;To assess the level of oxidative stress, the activity of the system of matrix metalloproteinases (MMP-1 and MMP-9) and their tissue inhibitor (TIMP-1) in the amniotic fluid of low birth weight premature newborns after abdominal delivery. Materials and methods:&amp;nbsp;The study included 142 women, 102 of whom were delivered by caesarian section within 28-33.6 weeks of gestation because of severe obstetric and/or perinatal complications (main group). The comparison group comprised 30 patients with term abdominal delivery, for obstetric indications. In 32 women of the main group and 30 of the comparison group the concentration of thiobarbitate-reactive products (TBRP) in amniotic fluid was determined by the photometric method on the KFC-3 spectrophotometer at 532 nm wavelength by changing the optical density, due to the coloring complex of the malone dialdehyde (MDA) with thiobarbitic acid in a ratio of 1:2. The concentrations of matrix metalloprothyinasis and their tissue inhibitors were determined by immunoformation with the vertical photometer Multiscan at 450 nm wavelength. Results:&amp;nbsp;The main indications for induced abdominal delivery are severe pre-eclampsia (38.2%), progress of placental insufficiency (24.5%), placental abruption (17.6%). In premature newborns, severe cerebral ischemia (p&amp;lt;0.05) is more commonly diagnosed after delivery induced for progressive fetal hypoxia (48.9%), and placental abruption (26.7%), while mild/medium cerebral ischemia is diagnosed after delivery for severe pre-eclampsia (54.4%). In the amniotic fluid of premature infants taken immediately after delivery, the concentration of TBRP, MMP-9, and the MMP/TIMMP-1 level was significantly higher and the TIMP-1 level was lower than that in newborns after term abdominal birth. Conclusion:&amp;nbsp;The obtained results demonstrate that premature infants, delivered by caesarian section for maternal indications, underwent antenatal hypoxia induced by life-threatening situations in the functional system &amp;laquo;mother-placenta-fetus&amp;raquo;, which is confirmed by the presence of oxidative stress, the high activity of the enzymes destroying collagen type IV and low level of tissue inhibitors of matrix metalloprothyinasis.</p></abstract><trans-abstract xml:lang="en"><p>Background:&amp;nbsp;Hypoxic brain injury is the most common pathology in newborns. New criteria of viability and progress of perinatal technologies results in high neurological morbidity of surviving very early preterm infants. The aim of the study:&amp;nbsp;To assess the level of oxidative stress, the activity of the system of matrix metalloproteinases (MMP-1 and MMP-9) and their tissue inhibitor (TIMP-1) in the amniotic fluid of low birth weight premature newborns after abdominal delivery. Materials and methods:&amp;nbsp;The study included 142 women, 102 of whom were delivered by caesarian section within 28-33.6 weeks of gestation because of severe obstetric and/or perinatal complications (main group). The comparison group comprised 30 patients with term abdominal delivery, for obstetric indications. In 32 women of the main group and 30 of the comparison group the concentration of thiobarbitate-reactive products (TBRP) in amniotic fluid was determined by the photometric method on the KFC-3 spectrophotometer at 532 nm wavelength by changing the optical density, due to the coloring complex of the malone dialdehyde (MDA) with thiobarbitic acid in a ratio of 1:2. The concentrations of matrix metalloprothyinasis and their tissue inhibitors were determined by immunoformation with the vertical photometer Multiscan at 450 nm wavelength. Results:&amp;nbsp;The main indications for induced abdominal delivery are severe pre-eclampsia (38.2%), progress of placental insufficiency (24.5%), placental abruption (17.6%). In premature newborns, severe cerebral ischemia (p&amp;lt;0.05) is more commonly diagnosed after delivery induced for progressive fetal hypoxia (48.9%), and placental abruption (26.7%), while mild/medium cerebral ischemia is diagnosed after delivery for severe pre-eclampsia (54.4%). In the amniotic fluid of premature infants taken immediately after delivery, the concentration of TBRP, MMP-9, and the MMP/TIMMP-1 level was significantly higher and the TIMP-1 level was lower than that in newborns after term abdominal birth. Conclusion:&amp;nbsp;The obtained results demonstrate that premature infants, delivered by caesarian section for maternal indications, underwent antenatal hypoxia induced by life-threatening situations in the functional system &amp;laquo;mother-placenta-fetus&amp;raquo;, which is confirmed by the presence of oxidative stress, the high activity of the enzymes destroying collagen type IV and low level of tissue inhibitors of matrix metalloprothyinasis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>preterm delivery</kwd><kwd>amniotic fluid</kwd><kwd>matrix metalloproteinases</kwd><kwd>oxidative stress</kwd></kwd-group><kwd-group xml:lang="en"><kwd>preterm delivery</kwd><kwd>amniotic fluid</kwd><kwd>matrix metalloproteinases</kwd><kwd>oxidative stress</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Radzinsky VE, Krasnopolsky VI, Logutova LS. Cesarean section. Problems of abdominal obstetrics. A guide for physicians. Saint Petersburg: SIMK; 2018. Russian.</mixed-citation></ref><ref id="B2"><mixed-citation>Betran AP, Ye J, Moller AB, et al. The increasing trend in caesarean section rates: global, regional and national estimates: 1990-2014. PLoS One. 2016;11(2):e0148343. DOI: https://doi.org/10.1371/journal.pone.0148343</mixed-citation></ref><ref id="B3"><mixed-citation>Visser GHA, Ayres-de-Campos D, Barnea ER, et al. FIGO position paper: how to stop the caesarean section epidemic. The Lancet. 2018;392(10155):1286-1287. DOI: https://doi.org/10.1016/S0140-6736(18)32113-5.3</mixed-citation></ref><ref id="B4"><mixed-citation>Sarbasova AE, Sinchikhin SP, Mamiev OВ, et al. Cesarean section in modern obstetrics: epidemiology, importance for prevention of obstetric and perinatal pathology, complications. Astrahanskij medicinskij zhurnal. 2016;2(11):57-63. Russian.</mixed-citation></ref><ref id="B5"><mixed-citation>Belousova VS, Strizhakov AN, Svitich OA, et al. Pretеrm birth: causes, pathogenesis, tactics. Obstetrics and Gynecology. 2020;2:82-87. Russian. DOI: https://dx.doi.org/10.18565/aig.2020.2.82-87</mixed-citation></ref><ref id="B6"><mixed-citation>WHO. Statement on Caesarean Section Rates. Geneva: World Health Organization [Internet]. 2015 [cited 2020 May 18]. Available from: http://www.who.int/reproductivehealth/ publications/maternal_perinatal_health/cs-statement/en/</mixed-citation></ref><ref id="B7"><mixed-citation>Ziyadinov AA, Sulima AN, Rybalka AN. The reasons for caesarean section in preterm labour. Tavricheskiy Mediko-Biologicheskiy Vestnik. 2015;18(1(69)):44-47. Russian.</mixed-citation></ref><ref id="B8"><mixed-citation>Khuzikhanov FV, Shayakhmetova RR, Valiev RI. Influence of various factors on the formation of diseases in children born by cesarean section [Internet]. Modern problems of science and education. 2016 [cited 2020 May 18];4. Russian. Available from: http://science-education.ru/ru/article/view?id=25086</mixed-citation></ref><ref id="B9"><mixed-citation>Kholodova IN, Zaidenvarg GE, Goryainova AN. Children after Caesarean section: how to improve their adaptation and reduce the risk of pathological conditions. Meditsinskiy sovet = Medical Council. 2019;11:16-22. Russian. DOI: https://doi.org/10.21518/2079-701X-2019-11-16-22</mixed-citation></ref><ref id="B10"><mixed-citation>. 2015;20:12-20. Russian.</mixed-citation></ref><ref id="B11"><mixed-citation>Umarova LN. Perinatal risk factors of birth of premature infants with very low and extremely low birth weight. Meditsinskie novosti. 2016;12:81-82. Russian.</mixed-citation></ref><ref id="B12"><mixed-citation>Hirono J, Sanaki H, Kitada K, et al. Expression of tissue inhibitor of metalloproteinases and matrix metalloproteinases in the ischemic brain of photothrombosis model mice. NeuroReport. 2018;29(3):174-180(7). DOI: https://doi.org/10.1097/WNR.0000000000000946</mixed-citation></ref><ref id="B13"><mixed-citation>De Luca C, Papa M. Matrix Metalloproteinases, Neural Extracellular Matrix, and Central Nervous System Pathology. Progress in Molecular Biology and Translational Science. 2017;148:167-202. DOI: https://doi.org/10.1016/bs.pmbts.2017.04.002</mixed-citation></ref><ref id="B14"><mixed-citation>Swarnakar S, Jana S. Matrix Metalloproteinases. In: Choi S, editor. Encyclopedia of Signaling Molecules, 2nd edition. Switzerland: Springer, Cham; 2018:3005-3013</mixed-citation></ref><ref id="B15"><mixed-citation>Shadrina AS, Tereshkina IV, Plieva YZ, et al. Matrix metalloproteinases: structure, functions and genetic polymorphism. Patogenez (Pathogenesis). 2017;2:14-23. Russian.</mixed-citation></ref><ref id="B16"><mixed-citation>Cui N, Hu M, Khalil RA. Biochemical and Biological Attributes of Matrix Metalloproteinases. Progress in Molecular Biology and Translational Science. 2017;147:25-29. DOI: https://doi.org/10.1016/bs.pmbts.2017.02.005</mixed-citation></ref><ref id="B17"><mixed-citation>Malinina EI, Chernysheva TV, Rychkova OA, et al. The concentration of matrix metalloproteinases is 2.9 in newborns with perinatal hypoxia [Internet]. Modern problems of science and education. 2019 [cited 2020 May 18];2. Russian. DOI: https://doi.org/10.17513/spno.28636 Available from: http://science education.ru/ru/article/view?id=28636.</mixed-citation></ref><ref id="B18"><mixed-citation>Chugunova TN, Korenovsky YV, Lobanov YF. Matrix metalloproteinases in neonates with hypoxic lesions of the central nervous system. Postgraduate doctor. 2016;1:188-194. Russian.</mixed-citation></ref><ref id="B19"><mixed-citation>Das S, Bandopadhyay S, Das S. Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease. Current Chemical Biology. 2014;8(31):184-214. DOI: https://doi.org/10.2174/221279680803150420095017</mixed-citation></ref><ref id="B20"><mixed-citation>Korenovsky YuV, Remneva OV. Reference values of concentrations of matrix metalloproteinases-1, -2, -9 and the tissue inhibitor of matrix metalloproteinases (TIMP-1) in the amniotic fluid during physiological pregnancy and delivery. Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry. 2016;10:240-242. DOI: https://doi.org/10.1134/S1990750816030070</mixed-citation></ref></ref-list></back></article>